MedTech Acquisition (MTAC) EBITDA

Annual EBITDA

-$2.75 M
+$294.60 K+9.69%

December 31, 2022

Summary

Performance

1-Year Change

+9.69%

3-Year Change

-

5-Year Change

-

15-Year Change

-

MTAC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.75 M
MTAC annual EBITDA is currently at an all-time high

3-Year Low

-$3.04 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
MTAC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
MTAC next annual earnings announcement has not yet been scheduled

OtherMTACprofitabilitymetrics:

Annual Revenue

-
MTAC annual revenue value is unknown

Annual Net Income

$5.54 M
MTAC annual net profit is $5.54 million

Annual EBIT

-$2.75 M
MTAC annual earnings before interest & taxes is -$2.75 million

Annual EPS

$0.19
MTAC annual earnings per share is $0.19

Quarterly EBITDA

-$1.43 M
-$586.70 K-69.57%

June 30, 2023

Summary

Performance

3-Month Change

-69.57%

1-Year Change

-396.01%

3-Year Change

-

5-Year Change

-

MTAC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$288.30 K

3-Year Low

-$1.43 M
MTAC quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
MTAC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
MTAC next earnings announcement has not yet been scheduled

OtherMTACprofitabilitymetrics:

Quarterly Revenue

-
MTAC quarterly revenue value is unknown

Quarterly Net Income

-$995.00 K
MTAC quarterly net profit is -$995.00 thousand

Quarterly EBIT

-$1.43 M
MTAC quarterly earnings before interest & taxes is -$1.43 million

Quarterly EPS

-$0.12
MTAC quarterly earnings per share is -$0.12

TTM EBITDA

-$4.06 M
-$1.14 M-39.10%

June 30, 2023

Summary

Performance

3-Month Change

-39.1%

1-Year Change

-39.71%

3-Year Change

-

5-Year Change

-

MTAC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$631.40 K

3-Year Low

-$4.06 M
MTAC TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
MTAC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
MTAC next earnings announcement has not yet been scheduled

OtherMTACprofitabilitymetrics:

TTM Revenue

-
MTAC TTM revenue value is unknown

TTM Net Income

-$1.13 M
MTAC TTM net profit is -$1.13 million

TTM EBIT

-$4.06 M
MTAC TTM earnings before interest & taxes is -$4.06 million

TTM EPS

-$0.15
MTAC TTM earnings per share is -$0.15

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$2.75 M
MTAC annual EBITDA is -$2.75 million

Annual Net Income

$5.54 M
MTAC annual net profit is $5.54 million

Annual Interest Expense

-
MTAC annual interest expense value is unknown

Annual Income Tax

$570.90 K
MTAC annual income tax is $570.90 thousand

Annual D&A

-
MTAC annual depreciation & amortization value is unknown

MTAC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.7%-396.0%-39.7%
3 y3 years---
5 y5 years---

MTAC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+10.7%+396.0%at low+60.4%at low
5 y5-yearat high+10.7%+396.0%at low+543.2%at low
alltimeall timeat high+10.7%+396.0%at low+543.2%at low

MedTech Acquisition EBITDA History

DateAnnualQuarterlyTTM
Jun 2023
-
-$1.43 M(+69.6%)
-$4.06 M(+39.1%)
Mar 2023
-
-$843.30 K(-37.8%)
-$2.92 M(+6.3%)
Dec 2022
-$2.75 M
-$1.36 M(+213.7%)
-$2.75 M(+8.5%)
Sep 2022
-
-$432.20 K(+49.9%)
-$2.53 M(-12.9%)
Jun 2022
-
-$288.30 K(-57.0%)
-$2.91 M(-14.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$669.80 K(-41.3%)
-$3.40 M(+11.9%)
Dec 2021
-$3.04 M
-$1.14 M(+41.4%)
-$3.04 M(+20.2%)
Sep 2021
-
-$807.30 K(+3.0%)
-$2.53 M(+46.8%)
Jun 2021
-
-$783.90 K(+154.5%)
-$1.72 M(+83.4%)
Mar 2021
-
-$308.00 K(-51.2%)
-$939.40 K(+48.8%)
Dec 2020
-
-$631.40 K
-$631.40 K

FAQ

  • What is MedTech Acquisition annual EBITDA?
  • What is the all time high annual EBITDA for MedTech Acquisition?
  • What is MedTech Acquisition annual EBITDA year-on-year change?
  • What is MedTech Acquisition quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MedTech Acquisition?
  • What is MedTech Acquisition quarterly EBITDA year-on-year change?
  • What is MedTech Acquisition TTM EBITDA?
  • What is the all time high TTM EBITDA for MedTech Acquisition?
  • What is MedTech Acquisition TTM EBITDA year-on-year change?

What is MedTech Acquisition annual EBITDA?

The current annual EBITDA of MTAC is -$2.75 M

What is the all time high annual EBITDA for MedTech Acquisition?

MedTech Acquisition all-time high annual EBITDA is -$2.75 M

What is MedTech Acquisition annual EBITDA year-on-year change?

Over the past year, MTAC annual EBITDA has changed by +$294.60 K (+9.69%)

What is MedTech Acquisition quarterly EBITDA?

The current quarterly EBITDA of MTAC is -$1.43 M

What is the all time high quarterly EBITDA for MedTech Acquisition?

MedTech Acquisition all-time high quarterly EBITDA is -$288.30 K

What is MedTech Acquisition quarterly EBITDA year-on-year change?

Over the past year, MTAC quarterly EBITDA has changed by -$1.14 M (-396.01%)

What is MedTech Acquisition TTM EBITDA?

The current TTM EBITDA of MTAC is -$4.06 M

What is the all time high TTM EBITDA for MedTech Acquisition?

MedTech Acquisition all-time high TTM EBITDA is -$631.40 K

What is MedTech Acquisition TTM EBITDA year-on-year change?

Over the past year, MTAC TTM EBITDA has changed by -$1.15 M (-39.71%)